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Despite its prominence as a concern among potential surgical candidates, there is little information in the literature regard-
ing the short- and long-term pain experience after living liver donation. We undertook a prospective study to examine (1)
the nature and incidence of acute and chronic pain after living donor hepatectomy and (2) the factors associated with an
increased or decreased risk of adverse pain outcomes. Before donation, a comprehensive assessment of potential predic-
tors of acute and chronic pain outcomes was conducted; this included donors’ pain expectations, psychosocial factors, med-
ical histories, and demographic factors. Detailed data regarding pain outcomes were collected postoperatively (days 1 and
2) and again during 6- and 12-month follow-up telephone interviews. Sixty-five adults (32 females and 33 males) scheduled
for donor hepatectomy participated. Substantial proportions of the donors reported a moderate-to-severe level of pain inten-
sity (4 on a 0-10 scale) at rest and after movement on day 1 (42% and 74%, respectively) and day 2 (33% and 32%,
respectively). Persistent postsurgical pain was reported by 31% of the donors at the 6-month follow-up and by 27% of the
donors at the 12-month follow-up. Generally, this pain was mild, and pain-related life interference was minimal. Female sex,
a younger age, and several predonation measures of pain-related anxiety were associated with a significantly greater risk of
developing persistent postsurgical pain. In conclusion, this study has identified a subset of patients who experience persis-
tent pain after living liver donation. Additional prospective research using larger samples of liver donors is needed to repli-
cate this work, to obtain a more detailed account of the acute and long-term pain experience, and to determine whether
targeted interventions can minimize the frequency and severity of chronic pain. Liver Transpl 20:1336-1346, 2014.
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Acute postsurgical pain is an expected outcome after
open surgical resection for living liver donation.1-3
However, there is accumulating evidence that some
living liver donors continue to experience pain beyond
the normal expected healing time.4 Chronic postsurgi-
cal pain (CPSP) is defined as pain lasting more than 2
months after a surgical procedure.5 It can negatively
affect the overall quality of life, including the ability to
return to work after surgery, and it can be extremely
costly from a health care perspective.6,7 The nature
and incidence of CPSP among liver donors remain
poorly described and understood, and little is known
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about the factors that may put donors at increased or
decreased risk.3,4,8
Short- and long-term follow-up studies of liver
donors have relied heavily on the Short Form 36 (SF-
36) to measure pain outcomes.9 The SF-36 is a
generic measure of health status that includes 2 items
about bodily pain (pain severity and life interference
due to pain). On the basis of this measurement tool,
the mean levels of bodily pain among samples of liver
donors have been reported to be as low as, or lower
than, those of the general population.4,10,11 Although
these studies are encouraging, researchers have typi-
cally aggregated SF-36 pain scores across donors and
thereby obscured a potential subset of donors with
chronic pain. The majority of studies have also used
cross-sectional designs in which predonation levels of
functioning were not assessed; this raises questions
about whether postdonation levels of pain and func-
tioning can be solely attributed to the donor surgery
(see Verbesey et al.,3 Chan et al.,4 and Erim et al.12
for exceptions).
In agreement with the broader literature on CPSP,
several studies have found that some liver donors do
indeed experience prolonged postoperative pain.13 For
example, in a cross-sectional study of 30 liver donors
(median time after donation51 year), 20% reported
ongoing wound pain, but the intensity was not speci-
fied.4 In a larger cross-sectional study of 83 donors
(median time after donation569 months), 6%
reported incisional discomfort requiring regular pain
medication, and 2% reported rib pain that interfered
with their daily activities.14 In a prospective study of
47 liver donors, the incidence and intensity of
surgery-related pain decreased over time; however, 6
months after donation, approximately 6% reported
the pain intensity as “somewhat painful,” and 19%
reported it as “not very painful.” By 12 months,
approximately 17% reported the continued presence
of pain but rated it as “not very painful.”3
In the context of other surgical procedures (eg, her-
nia repair, thoracotomy, coronary bypass surgery, and
limb amputation), systematic literature reviews have
suggested that biomedical and demographic factors
can play a role in the development and maintenance of
CPSP.15-24 One of the strongest risk factors for persis-
tent postsurgical pain appears to be pain severity in
the first few days after surgery.17 Therefore, even
though pain is an expected outcome of liver donor sur-
gery, donors who experience high levels of acute post-
operative pain may be at a greater risk of developing a
persistent pain condition. Psychological factors, includ-
ing pain-related anxiety and pain catastrophizing, have
been linked to higher levels of postoperative pain and
to a greater likelihood of transitioning from acute pain
to chronic pain.16,25-27 Preoperative expectations of
high levels of postsurgical pain as well as a more gen-
eralized fear of surgery have also been found to predict
more intense pain after surgery.28,29
In the present study, we used a prospective study
design to address questions and concerns related to
the pain experience after living liver donation.3,8,27,30
The first study aim was to describe the pain experi-
ence of donors during the first 2 days after surgery
and to compare this to donors’ presurgical expecta-
tions about postsurgical pain. The second aim was to
describe the nature and incidence of persistent post-
surgical pain at 6- and 12-month follow-ups. The
third and final aim was to explore demographic, surgi-
cal, and psychological factors associated with CPSP
reported at the 6- and 12-month follow-up interviews.
PATIENTS AND METHODS
Participants and Recruitment
Institutional review board approval was obtained
(REB 03-0270-AE), and all participants provided
informed consent before participation. This prospec-
tive study was part of a larger investigation that
recruited other surgical populations (eg, lateral thora-
cotomy, abdominal-gynecological, and orthopedic
patients). The present study presents data from
adults (18 years old or older) who were scheduled for
donor hepatectomy at Toronto General Hospital, a
major liver transplantation center located in Toronto,
Canada. Donors were recruited for participation dur-
ing a pre-admission hospital visit approximately 1
week before the donor surgery. The study recruitment
and the donor surgeries took place between November
2003 and November 2008. All patients were followed
by the acute pain service (APS) managed by the
Department of Anesthesia and Pain Management. The
APS followed patients with standardized protocols for
postoperative pain management, and these protocols
remained consistent throughout the data collection
period. Patients received either intravenous (IV)
patient-controlled analgesia (PCA) or patient-
controlled epidural analgesia (PCEA). Patients with tho-
racic epidurals placed below the T6 dermatome received
a 0.1% bupivacaine solution with 0.015 mg/mL hydro-
morphone. The epidural infusion was delivered via a
Gemstar pump (Abbott, Lake Forrest, IL) at a rate of
5 mL/hour (with a 3-mL bolus, a 20-minute lockout
period, and a 4-hour maximum of 50 mL). IV PCA was
administered via an Abbot PCA II pump (Abbott, Lake
Forrest, IL) with hydromorphone in 0.4 mg/mL boluses
at a dose of 0.2 to 0.4 mg with a 5-minute lockout
period and a 4-hour maximum of 10 mg or with mor-
phine in 1 mg/mL boluses at a dose of 1.0 to 2.0 mg
with a 5-minute lockout period and a 4-hour maxi-
mum of 40 mg. A standardized algorithm was in place
so that the APS physician would adjust the epidural
rate or IV PCA settings when necessary to ensure
patient comfort. Patients were followed by the APS
until the IV PCA or PCEA was discontinued and the
patients were switched to oral analgesia (narcotics
and low-dose acetaminophen). The APS reviewed
analgesics again before patient discharge.
Procedure
Data for the present study were collected at 4 time
points: (1) preoperatively, (2) postoperatively (days 1
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and 2), (3) at a 6-month follow-up, and (4) at a 12-
month follow-up. Preoperatively, during the pre-
admission hospital visit approximately 1 week before
the donor surgery, participants completed a set of
written questionnaires assessing their expectations
for postsurgical pain, psychosocial factors (trait anxi-
ety, pain anxiety, anxiety sensitivity, and pain catas-
trophizing), medical history, and demographic factors.
Approximately 24 and 48 hours after the surgery,
donors reported their pain intensity scores at rest and
after a standardized movement. Six and 12 months
after the surgery, participants took part in telephone
interviews that focused on the details of any ongoing
pain problems that they had experienced as a result
of the donor surgery.
Attrition
Eighty donors agreed to participate in this study: 3
had their surgeries cancelled, 2 surgeries were
rescheduled (without the researchers being notified),
and 10 donors did not provide sufficient data to be
included in the analyses. Two of those with insuffi-
cient data withdrew themselves from the study before
the surgery, 3 withdrew themselves after the surgery
(but before the postoperative pain assessment on day
1), 1 withdrew between the day 1 and day 2 postoper-
ative pain assessments, 1 did not complete the base-
line questionnaires or the postdischarge follow-up
interviews, and 3 were excluded because, although
they consented to participate, they did not complete
any of the study measurements. In all, 65 donors
responded to preoperative questions regarding their
pain expectancies, medical history, and demo-
graphics, and 57 of those 65 donors (87.7%) com-
pleted the preoperative psychosocial questionnaires.
Postoperatively, 63 donors (96.9%) responded to
pain-related questions. Fifty-five of the 65 donors
(84.6%) took part in the 6-month follow-up telephone
interview, and 52 of the 65 donors (80%), including 6
who could not be reached at 6 months, took part in
the 12-month follow-up interview. Donors who failed
to complete the 6- and/or 12-month follow-up did
not differ significantly in age, sex, or postoperative
pain levels at 24 and 48 hours from those who com-
pleted the 6- and 12-month follow-up interviews (all
P values>0.15).
Measures
Preoperative Assessment
Pain-Related and Demographic Variables. Partici-
pants were asked to rate the pain intensity and pain
unpleasantness that they expected to experience
after donor surgery with an 11-point numerical rat-
ing scale (NRS) ranging from 0 (no pain) to 10 (worst
possible pain). The NRS is a brief, easy-to-use pain
assessment tool that has demonstrated strong reli-
ability and validity in previous studies of acute and
chronic pain patients (including surgical popula-
tions).31-33 Participants were also asked a series of
detailed questions about past surgeries and pain
conditions as well as any ongoing pain problems (for
more information on this questionnaire, see Page
et al.34). Lastly, a variety of demographic factors (eg,
age, ethnicity, and employment status) were
assessed.
Psychosocial Variables. Participants also completed
a set of standardized measures of psychological fac-
tors (pain disability, trait anxiety, pain anxiety, anxi-
ety sensitivity, and pain catastrophizing) that have
been shown to be predictive of acute and chronic
postoperative pain. These measures have shown
strong reliability and validity in studies of surgical
patients and those with acute and chronic
pain.25,35,36 In the current study, Cronbach’s a was
strong for the total and subscale scores of all meas-
ures (ranging from 0.75 to 0.95), with the exception of
the social concerns subscale of the Anxiety Sensitivity
Index (ASI; 0.52) and the magnification subscale for
the Pain Catastrophizing Scale (PCS; 0.53). The
details of these measures are outlined next.
Pain disability was measured with the Pain Disabil-
ity Index (PDI), which is a 7-item scale assessing the
degree to which pain interferes with 7 life domains
(family/home responsibilities, recreation, social activ-
ity, occupation, sexual behavior, self-care, and life-
support activity).37
Trait anxiety (the stable tendency to experience fre-
quent state anxiety) was assessed with the 20-item
trait subscale of the Spielberger State-Trait Anxiety
Inventory.38
Pain-related anxiety was assessed with the Pain
Anxiety Symptoms Scale 20 (PASS-20), a 20-item
measure designed to assess fear and anxiety
responses to pain.39 The PASS-20 consists of four 5-
item scales measuring cognitive anxiety, escape and
avoidance responses, fearful thinking, and physiologi-
cal anxiety responses.
Anxiety sensitivity was assessed with the ASI, a 16-
item measure of the degree to which individuals fear
cognitive or somatic symptoms of anxiety because of a
belief that these symptoms may be dangerous or
harmful.40 The ASI comprises 1 higher order factor
(the ASI total score) and 3 lower order factors: the fear
of physical symptoms of anxiety, the fear of losing
mental control, and the fear of looking nervous to
others.41
Pain catastrophizing was assessed with the PCS, a
13-item scale that measures catastrophic thinking
related to pain.42 Participants reflect on past painful
experiences and indicate the degree to which they
experience a variety of thoughts and feelings. The PCS
provides a total score and 3 subscale scores assessing
pain rumination, magnification, and helplessness.
Postsurgical Assessment
Approximately 24 and 48 hours after the surgery,
participants were asked to rate their present pain
intensity at rest and after a standardized movement
with an 11-point NRS ranging from 0 (no pain) to 10
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(worst possible pain), with the endpoints represent-
ing the most extreme pain experiences. The assess-
ment of movement-evoked pain involved having the
patient sit up in bed from a lying position and then
provide a pain rating. This is a common method for
assessing movement-evoked pain after surgery in
the abdominal area.43 Pain ratings were obtained at
approximately the same time of day (between 2 and
4 PM) by research nurses who were dedicated solely
to working on research projects and who were
trained in the pain assessment methods used here.
NRS ratings4 were considered to be in the
moderate-to-severe range.44
6- and 12-Month Follow-Up Assessments
Telephone interviews were conducted 6 and 12
months after the surgery to assess pain related to
the donor hepatectomy. Using an NRS [ranging from
0 (no pain) to 10 (worse possible pain)], donors were
asked to recall, at its worst, how intense and
unpleasant the pain was after their operation and to
indicate how long it took for their surgical pain to go
away completely. Those donors who reported that
they were still experiencing pain due to surgery were
asked about the nature of this pain (eg, present pain
intensity, frequency, location, and pain-related life
interference) and if they had returned to work or to
regular activities since the operation.34 Donors also
completed the PDI during the 6- and 12-month
interviews.37
RESULTS
Sample Characteristics
A detailed description of the demographic and medical
characteristics of the sample is provided in Table 1.
The final sample comprised 65 liver donors (32 females
and 33 males) with a mean age of 38.7 years [standard
deviation (SD)511.8, range520-59 years] at the time
of donation. The majority of the sample was Caucasian
(87.7%) and had at least a high school education
(98.5%). Before the donor surgery, 11 donors (16.9%)
reported an ongoing pain problem (defined as pain
lasting longer than 1 month). The diagnosis and loca-
tion of this pain varied widely and included neck or
back pain (n53), arthritis (n52), leg pain (n53),
headaches (n51), and a rotator cuff tear (n51). Nota-
bly, none reported preoperative pain at the site of the
proposed incision. The standard incision for living liver
donors at our institution is a subcostal incision. The
majority of the participants (66.7%) underwent left
donor hepatectomy, and the remainder underwent
right donor hepatectomy. Most donors (60.3%) received
IV PCA, 36.5% received PCEA, and 3.2% received both
IV PCA and PCEA. Complications in the present sam-
ple were graded according to the revised Clavien classi-
fication system.45 Sixty donors (92.3%) had at least 1
in-hospital grade I complication, with the most com-
mon being nausea (75.4%), pruritus (53.8%), vomiting
(38.5%), gas pain (18.5%), headache (15.4%), and diz-
ziness (12.3%). For the majority of the donors (75%),
these were mild in severity. Donors’ symptoms resolved
before discharge with the exception of 1 donor who
had mild constipation. Lastly, 7 donors (10.8%) had a
grade II or higher complication while they were in the
hospital (urinary retention requiring recatheterization,
n55; bilateral pleural effusion, n51; or pulmonary
embolism, n51).
Postoperative Pain Expectancies and Outcomes
Donors’ expected and actual postoperative pain
intensity ratings are presented in Fig. 1. Before dona-
tion, donors expected a mean postoperative pain
intensity of 7.9 (SD51.8) and a mean postoperative
pain unpleasantness of 7.6 (SD51.8). However, on
day 1 after the surgery, the mean pain intensity rat-
ings at rest and after movement were 3.2 (SD52.2)
and 5.4 (SD52.5), respectively. On day 2, the mean
pain intensity ratings at rest and after movement
were 2.7 (SD52.1) and 4.8 (SD52.5), respectively.
At the 6-month interview, donors’ retrospective
reports of their worst pain intensity and pain
unpleasantness since surgery were 7.3 (SD52.5)
and 7.0 (SD52.6), respectively. At 12 months, the
retrospective reports of the worst pain intensity and
unpleasantness since surgery were 7.1 (SD52.2)
and 6.7 (SD52.3), respectively. The results of a
repeated measures analysis of variance revealed a
statistically significant difference between donors’
presurgical pain intensity expectations and donors’
actual postsurgical pain intensity ratings [days 1 and
TABLE 1. Sample Characteristics Before Donor
Surgery
Sex: female [n (%)] 32 (49.2)
Age (years)* 38.7611.8 (20-59)
Ethnicity: Caucasian [n (%)] 57 (87.7)
Education [n (%)]
Less than high school 1 (1.5)
High school degree 21 (32.3)
University or college degree 37 (56.9)
Graduate degree 6 (9.2)
Currently employed [n (%)] 56 (86.2)
Body mass index (kg/m2)* 25.163.5
(18.7-34.1)
Ongoing pain problem [n (%)] 11 (16.9)
Average pain intensity
(when in pain)*
5.663.3 (1-10)
Pain-related disability
(PDI)*
8.6614.5 (0-46)
Life interference due
to pain (n)
Not at all 2
Slightly 3
Moderately 4
Severe 1
*The data are presented as means and SDs (with ranges
in parentheses).
LIVER TRANSPLANTATION, Vol. 20, No. 11, 2014 HOLTZMAN ET AL. 1339
2 after surgery and recall of worst pain at 6 and 12
months; F(6)549.2, P<0.001]. Post hoc analyses
indicated that donors’ expectancies for postdonation
pain intensity were significantly higher than donors’
actual postdonation ratings of pain intensity (all P
values<0.05). It is important to note that, although
expectancies for postdonation pain were statistically
higher than donors’ 6- and 12-month recollections of
their worst pain, the difference was small and below
the 2-point difference required to be clinically
meaningful.46
Pain Outcomes at the 6- and 12-Month Follow-
Up Interviews
At the 6-month follow-up interview, donors reported
that their surgical pain had completely gone away
within several days (n51), 1 to 2 weeks (n58), 3 to 4
weeks (n510), 5 to 8 weeks (n59), or 3 to 4 months
(n511) after surgery. Details regarding the cases of
persistent postsurgical pain at 6 and 12 months are
provided in Table 2. At the 6-month follow-up inter-
view, 17 donors (30.9%) reported that they were still
experiencing pain related to their donor surgery.
Three of the 17 donors reported an average pain level
in the moderate-to-severe range. Eight of the 17
donors who were still experiencing pain at 6 months
reported ongoing pain at 12 months, 7 reported that
their pain had gone away completely by 12 months,
and 2 failed to complete the 12-month follow-up
interview.
At the 12-month follow-up interview, 14 donors
reported experiencing persistent postsurgical pain [ie,
the 8 who reported pain at 6 months plus another 6
donors (3 of whom had said their surgical pain had gone
away at the 6-month interview and 3 who had not com-
pleted the 6-month follow-up interview, so their pain
status at that time is unknown)]. Among the 14 donors
(26.9%) who were still experiencing pain at 12 months,
5 reported pain in the moderate-to-severe range.
Factors Associated With Postoperative and
Persistent Pain After Donor Surgery
A series of bivariate analyses (independent sample t
tests and chi-square tests) were conducted to explore
factors related to postsurgical pain intensity (aggre-
gated across days 1 and 2) and the presence (yes/no)
of CPSP at the 6- and 12-month follow-ups. The fol-
lowing factors were examined: psychosocial factors
(predonation expectancies for postsurgical pain and
pain unpleasantness, pain anxiety, pain catastrophiz-
ing, anxiety sensitivity, and trait anxiety), medical fac-
tors (body mass index, ongoing pain problem and
pain-related disability before donation, IV PCA versus
PCEA, right versus left hepatectomy, and Clavien
grade I and II in-hospital complications), and demo-
graphic factors (age and sex). When we were testing
predictors of CPSP, the following additional factors
were explored: postsurgical pain intensity (at rest and
movement-evoked) and retrospective recall of the
worst pain intensity and unpleasantness since
Figure 1. Pain following living liver donation: predonation expectancies and postdonation pain ratings. Data are presented as means
and standard errors of the mean. The sample sizes for each time point are as follows: before surgery, n565; day 1 after surgery,
n562; day 2 after surgery, n563; 6-month follow-up, n555; and 12-month follow-up, n552. Presurgical expectancies for postsurgi-
cal pain were obtained approximately 1 week before surgery. R indicates pain intensity at rest, M indicates pain intensity after stan-
dardized movement, and W indicates the recollection of the worst pain since surgery.
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surgery (provided during the 6- and 12-month inter-
views). Because of the exploratory nature of these
analyses and our goal of avoiding type II errors (in
order to identify candidate variables for further
research), factors that were related to pain outcomes
at P<0.10 were considered statistically significant. As
a result, findings should be interpreted with caution,
particularly because of the large number of compari-
sons that were conducted.
Postoperative Pain (Rest)
Younger donors reported significantly greater levels
of postoperative pain at rest [r(64)520.26, P50.04].
The use of PCEA (versus IV PCA) was associated with
lower postoperative pain at rest [t(58)51.79,
P50.08]. Donors with an ongoing pain problem
before surgery also reported lower postoperative pain
intensity at rest than those who did not report an
ongoing pain problem [t(62)521.75, P50.09].
Postoperative Pain (Movement-Evoked)
Younger donors reported greater levels of movement-
evoked pain [r(64)520.22, P50.08]. Donors who
reported greater expectations for pain unpleasantness
[r(64)50.27, P50.03] and who scored higher on the
PASS-20 cognitive anxiety subscale [r(56)50.31,
P50.02] and the PASS-20 total scale score
[r(56)50.22, P50.098] reported greater movement-
evoked pain intensity. Lastly, higher scores on the
PCS magnification subscale were associated with
higher levels of movement-evoked pain [r(56)50.24,
P50.07].
Persistent Pain (6-Month Follow-Up)
Female donors were significantly more likely to report
persistent postsurgical pain at the 6-month follow-up
[v2(1)55.37, P50.02 (relative risk52.68, 95% con-
ference interval51.09-6.58)]. In fact, 12 of the 17
donors (71%) who reported persistent pain at 6
months were female. Greater postoperative pain inten-
sity at rest and after movement (averaged across days
1 and 2) was not associated with a greater risk of per-
sistent pain [t(53)51.52, P50.14 (Cohen’s d50.42)
for rest; t(53)50.72, P50.48 (Cohen’s d50.20)] for
movement. However, during the 6-month interview,
donors who recalled a higher worst level of pain inten-
sity after surgery were significantly more likely to
TABLE 2. Description of Living Liver Donors Who Continued to Experience Pain 6 and/or 12 Months After the Donor
Surgery
6-Month Follow-Up (n517) 12-Month Follow-Up (n514)
Location of pain* Abdomen (n56) Abdomen (n52)
Incision site (n58) Incision site (n58)
Under/around rib cage (n52) Back (n51)
Right side (n51) Right side (n55)
Pain frequency Constant (n54) Constant (n53)
Periodic (n58)† Periodic (n54)§
Brief (n55)‡ Brief (n57)k
Average pain intensity¶ 2.862.2 (1-8) 2.961.4 (1-5)
Average pain unpleasantness¶ 2.862.1 (0-8) 2.261.3 (0-5)
PDI¶ 6.5611.7 (0-37) 5.968.6 (0-27)
Life interference due to pain Not at all (n59) Not at all (n57)
Slightly (n56) Slightly (n53)
Moderately (n51) Moderately (n54)
Severely (n51)
Returned to work or regular activities Yes (n514) Yes (n511)
Yes with modified
responsibilities (n51)
Yes with modified
responsibilities (n52)
No (n52) No (n51)
Ongoing pain problem before donation Yes (n54) Yes (n50)
No (n513) No (n514)
NOTE: Pain intensity and pain unpleasantness were scored on a possible scale of 0 to 10, and pain disability was scored
on a possible scale of 0 to 70, with higher scores reflecting worse functioning.
*Some donors reported more than 1 pain location.
†Donors described this periodic pain as occurring more than once a day (n51), daily (n51), more than once a week
(n52), or weekly (n54).
‡Donors described this brief pain as occurring more than once per week (n52) or weekly (n53).
§Donors described this periodic pain as occurring daily (n52), more than once per week (n51), or weekly (n51).
kDonors described this brief pain as occurring daily (n51), more than once per week (n53), weekly (n51), or monthly
(n52).
¶The data are presented as means and SDs (with ranges in parentheses).
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report persistent pain at the 6-month follow-up
[t(53)53.05, P50.004 (Cohen’s d50.84)].
Persistent Pain (12-Month Follow-Up)
Female sex was also related to persistent pain at 12
months: 10 of the 14 donors (71%) with persistent
pain were female [v2(1)52.92, P50.09 (relative
risk52.32, 95% conference interval50.83-6.45)].
Donors who scored higher on the social concerns sub-
scale of the ASI were more likely to report persistent
pain at the 12-month follow-up [t(42)52.84,
P50.007 (Cohen’s d50.88)]. Lastly, donors who
recalled a significantly worse level of pain unpleasant-
ness (during the 12-month interview) were more likely
to report CPSP [t(50)52.28, P50.03 (Cohen’s
d50.64)]. Recollections of the worst pain intensity
were not significantly related to CPSP [t(50)51.62,
P50.11 (Cohen’s d50.46)].
DISCUSSION
The present prospective study represents the most
comprehensive examination of pain outcomes among
liver donors to date. On average, donors reported a
mild level of pain intensity (at rest) during the first 2
days after their surgery. However, a closer examina-
tion of the data reveals that a substantial proportion
of the donors experienced moderate-to-severe levels of
acute postsurgical pain (defined as an NRS pain
intensity score of 4 or more).44 On day 1, the propor-
tions of donors who reported moderate-to-severe pain
were 41.9% (at rest) and 74.2% (after movement), and
on day 2, the proportions were 33.3% (at rest) and
31.7% (after movement). The majority of the donors
reported a complete resolution of postsurgical pain
within 6 months or 1 year, and this is in line with pre-
vious research.3,4,8 However, in agreement with our
hypotheses, we found that 17 of the 55 donors
(30.9%) who completed the 6-month follow-up inter-
view reported CPSP, and 14 of the 52 donors (26.9%)
reported CPSP at the 12-month follow-up. Although
we did not formally assess the possibility that the
postoperative pain was a continuation of an existing
pain problem,5 it is notable that for none of the
patients who reported preoperative pain was its loca-
tion at the site of the proposed incision. The preva-
lence rates of CPSP after other abdominal surgeries (eg,
open cholecystectomy, hysterectomy, and hernia repair)
vary widely from 5% to more than 50%.17,18,47-49 This
variability is due to a number of factors, including
the specific type of surgery/incision, intraoperative
nerve damage, the duration of surgery, the timing of
follow-up, the method of pain assessment, and the
minimum pain score required for classification as
chronic pain–positive.17,18 Although it is difficult to
draw a direct comparison, the CPSP rates for our
sample of living liver donors do fall within the range
for other major abdominal surgeries.
It is important to point out that the intensity of
CPSP was mild for most donors. Moreover, the major-
ity of donors with CPSP described the frequency of
their pain as brief and/or periodic, and they reported
that pain-related disability was generally absent or
minimal. Three donors (at the 6-month follow-up) and
5 donors (at the 12-month follow-up) reported persis-
tent postsurgical pain in the moderate-to-severe
range, and these incidence rates (5.5% and 9.6%) are
consistent with previous studies of living liver
donors.3,14 All 5 of these donors indicated that their
CPSP was “not at all” interfering with their life. This
may reflect the careful screening process that occurs
before donation to ensure that prospective donors are
emotionally and physically high-functioning.
Two demographic factors emerged as important pre-
dictors of pain outcomes in this study of living liver
donors: age and sex. Younger donors were more likely
to report higher levels of acute postoperative pain, and
this is consistent with a number of previous studies of
other surgical procedures.50,51 Several explanations for
this, including a decrease in peripheral nociceptive
functioning with increasing age, have been proposed.52
In predicting CPSP, age was no longer a significant fac-
tor. Indeed, there continues to be some controversy
about whether younger age is associated with a greater
risk of developing CPSP. In contrast, acute levels of
postoperative pain were not significantly different
between male and female donors; however, females
were more than 2 times more likely to report CPSP at
the 6- and 12-month follow-up in comparison with
males. The finding that 71% of those with CPSP were
women is consistent with a large body of research
showing a greater prevalence of chronic pain condi-
tions among women.20 A number of studies have found
higher levels of postoperative pain in women versus
men.20,21 However, research regarding sex differences
in postoperative pain has been equivocal.20,50 Sex dif-
ferences in acute and chronic pain likely arise from a
number of complex and interacting biological, psycho-
logical, and social mechanisms.53,54 Clearly, one would
not want to rule out prospective donors because they
were young or female. However, the present findings
do suggest that there may be room for improvement in
the treatment of acute postoperative pain of younger
donors and a need for measures to address the ele-
vated risk for CPSP among female liver donors. The
lack of an association between donor complications
and pain outcomes is also noteworthy. This may have
been due to the fact that the vast majority of the com-
plications were mild and transient in nature (eg, nau-
sea and pruritus), and this does not exclude the
possibility that surgical complications can put donors
at risk for adverse pain outcomes.17,18
Several anxiety-related factors were also associated
with pain outcomes. Donors who reported a predona-
tion tendency to respond to pain with fear and anxiety
and, in particular, with higher levels of cognitive anxi-
ety (eg, worry and rumination) reported significantly
more intense postoperative pain after standardized
movement. A tendency to experience exaggerated neg-
ative thoughts and feelings about pain (eg, fearing
that pain might get worse) was also associated with
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greater postoperative pain intensity. The only other
anxiety factor that was associated with pain outcomes
was the social concerns subscale of the ASI, which
was related to a greater likelihood of CPSP at the 12-
month follow-up. More general levels of trait anxiety
(Spielberger State-Trait Anxiety Inventory) and anxiety
sensitivity were not related to any donor pain out-
comes. These mixed findings mirror the broader liter-
ature regarding anxiety as a risk factor for CPSP.
There is evidence that preoperative (pain-specific and
general) anxiety confers a risk for CPSP, but there is
variability across studies regarding which specific
scales and subscales are most important.55-58
The role of predonation expectancies regarding
acute postsurgical pain and CPSP was also explored.
In the present study, donors who expected greater
pain unpleasantness reported significantly greater
movement-evoked pain on days 1 and 2 after sur-
gery. However, expectancies for postsurgical pain
intensity and pain unpleasantness did not affect the
likelihood of developing CPSP. Our results also
revealed a striking discrepancy between expected
and actual pain outcomes, such that donors
expected a significantly higher level of postsurgical
pain (7.85 on the 0-10 NRS) than they actually
reported on days 1 and 2 after surgery. On one
hand, this may reflect a true disconnect between
donors’ expected and actual pain outcomes. Indeed,
a previous study of 226 liver donors at our center
found that the average pain intensity reported at 6 PM
and midnight on the day of surgery was less than 4
on the 0 to 10 NRS.1 On the other hand, donors’ pain
ratings on days 1 and 2 after surgery may represent
an underestimate of the acute pain experience.59 For
example, donors in the current study were asked to
report their present pain at 24 hours, not their worst
pain over the past 24 hours. It is also possible that
some donors may have underreported their pain to
put on a brave face for their health care team and
their recipients.
Donors’ preoperative pain expectancies were much
closer to the worst level of pain that they reported
since donation (when they were queried during the 6-
and 12-month follow-up interviews). However,
because of the way these follow-up questions were
worded, we cannot pinpoint exactly when donors
experienced their worst pain after donation (eg, during
the first hours or days in the hospital or after dis-
charge). It is also difficult to tease apart whether the
higher pain reports at 6 and 12 months are accurate
recollections or whether these recollections may
reflect a retrospective recall bias or a preoperative
expectancy bias.60 The fact that donors (on average)
expected such a high level of pain intensity is interest-
ing because living liver donors at our center take part
in a discussion of pain and pain modalities during the
preadmission hospital visit, during which most are
informed that they will likely experience a mild-to-
moderate level of pain intensity after the surgery.
One possibility raised by our findings is that the 6-
and 12-month reports are in fact accurate and that
pain becomes more intense once donors are dis-
charged from the APS and/or hospital because they
no longer have access to the superior in-hospital pain
control regimen (eg, PCEA and IV PCA). This is clearly
supported by the literature for other surgical proce-
dures (eg, total knee arthroplasty).61 Prospective data
on the intensity of acute pain in the hours after sur-
gery and during the initial days and weeks after
patients have been discharged home are needed to
ascertain the extent to which the discrepancies
between actual pain and expected pain are accurate
or are due to recall bias. A prospective examination of
different pain trajectories among donors [eg, those
who experience constant pain (pain at 6 and 12
months) and those who experience decreasing pain
(pain at 6 months but not at 12 months)] and predic-
tors of these trajectories is also warranted. Neverthe-
less, among those who continued to report pain at the
6- and 12-month follow-ups, the extent to which the
pain interfered with everyday activities was low for
most donors (see Table 2).
The present study has a number of limitations.
First, the relatively small sample size may have hin-
dered our statistical power to identify risk factors for
acute and persistent postsurgical pain. We used a
more liberal criterion for statistical significance to
address this issue, but this may have led to a greater
likelihood of a type II error. We also tested a large
number of candidate predictors of pain outcomes.
This inclusive approach was employed because of the
challenges of obtaining detailed prospective data on
liver donors. Second, the generalizability of these find-
ings to other liver donor populations is yet to be
determined, particularly because this study was lim-
ited to a single center. The main focus of the present
study was the incidence and predictors of postopera-
tive pain and CPSP. Therefore, it is possible that there
may have been a self-selection bias by which donors
with more pain were more likely to participate in the
follow-up interviews. However, the finding that donors
who completed the 6- and 12-month follow-up inter-
views did not differ significantly from those who did
not in terms of their pain scores on postoperative
days 1 and day 2 suggests that this was not the case.
Third, there may be other donor-specific psychosocial
factors (eg, stress and depression) as well as center-
specific factors that are associated with donor pain
outcomes that we did not assess in the present
study.21 Fourth, the reliability of 2 of the anxiety sub-
scales (social concerns of the ASI and magnification of
the PCS) was low. Thus, even though they were pre-
dictors of pain outcomes, these findings should be
interpreted with caution. Similarly, because of the
large number of statistical comparisons, findings need
to be replicated in future research. Fifth, postopera-
tive pain assessment was limited to 2 time points
(days 1 and 2), and because PCA is the standard of
care at our center, this may have introduced some
additional variability into the postoperative pain data.
By focusing on the first 48 hours after surgery, we
also may not have captured the pain experience
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during important transitions, such as increases in
mobility (eg, hallway walking) and the transition to
oral analgesics. Lastly, 36.5% of our sample received
PCEA. The use of epidurals in the adult living liver
donor population has decreased at many centers (and
they are no longer being used at our institution)
because of concerns about the risk of epidural hema-
toma. Thus, the acute pain profile reported in this
study may actually be worse today than when these
data were collected. Our previous retrospective study
showing that, in comparison with IV PCA, PCEA pro-
vides superior pain relief during the first 3 days after
living liver donation supports this suggestion.23 Cur-
rently, our center is evaluating the use of medial open
transversus abdominis plane catheters to better man-
age pain after open liver resection as an alternative to
PCEA and IV PCA (Karanicolas et al.).62
Understanding and improving pain outcomes among
living liver donors has been identified as a key priority
by liver transplant clinicians and researchers and is a
current focus of the National Institutes of Health–
funded Adult-to-Adult Living Donor Liver Transplan-
tation Cohort Study.1,23,63,64 The use of a prospective
design in the present study allowed for unique
insights into pain outcomes, and it suggests that
there continues to be room for improvement in the
management of pain after donor hepatectomy. At least
one-third of the donors reported moderate-to-severe
pain at rest on days 1 and 2 after surgery, and more
than one-quarter of the donors indicated the presence
of persistent postsurgical pain at the 6- and 12-
month follow-ups (although life interference due to
pain was minimal). Findings from the present study
indicate that donors who are younger, are female, and
report pain-related anxiety are at higher risk of devel-
oping CPSP. By targeting and intervening with these
at-risk individuals, we may be able to improve short-
and long-term pain outcomes. A recent randomized
controlled trial showed that a brief psychological
intervention before surgery improved many outcomes
after living liver donation, including pain at 3
months.65 More generally, donors may benefit from a
greater focus on pain management during discharge
planning and, in particular, on addressing barriers to
effective pain management in the home (eg, undesir-
able side effects and underprescribing).
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